Table 1

Characteristics of patients with bronchoscopic RML reduction with EBVs

Case reportsThis caseCase 2 [8]Case 3 [8]Case 4 [8]Case 5 [7]Case 6 [6]
Demographics and clinical data
SexMaleMaleFemaleMaleMaleFemale
Age, years575266506565
Smoking status (pack-years)Past (50)Past (35)Past (20)PastPast (80)Past (20)
mMRC class4
6MWD, m250230
EBV targetRML emphysemaRML bullaRML bullaRML bullaRML bulla 15.0×10.1 cmRML bulla 12.7×10.1 cm
Pulmonary function tests
RV, L (% pred)8 (340)5.37 (215.8)6.43 (275)3.54 (182)
FVC, L (% pred)2.3 (49)
FEV1, L (% pred)0.8 (23)1.07 (35.4)0.71 (38.3)0.74 (19.7)0.41 (13)0.74 (36)
After EBV procedure
Follow-up, months2666212
mMRC class2 (+2)
RV, L (gain)5.9 (−2.1 L)4.74 (−1.69 L)2.89 (−0.65 L)
FVC, L (gain, L and %)3.5 
(+1.2 L, +52%)
FEV1, L (gain, mL and %)1.2 
(+400 mL, +50%)1.75 
(+680 mL, +63%)1.03 
(+320 mL, +45%)0.83 
(+90 mL, +12%)0.58 
(+170 mL, +41%)0.86 
(+120 mL, +16%)
6MWD, m (change m and % gain)360 
(+110 m, 31%)300 (+70 m)
OutcomeImprovedImprovedImprovedNo benefitImprovedImproved